Rivian Rallies as Tesla Stalls; NIO Slips on Rally Maneuvers and R2 Growth
Rivian shares jumped about 8% amid a crucial R2 production debut and rising software revenue, even as peers Tesla and...
We evaluate long-term return potential across index funds to help you identify candidates with the strongest growth prospects.
28,522 articlesRivian shares jumped about 8% amid a crucial R2 production debut and rising software revenue, even as peers Tesla and...
Beyond Meat is shifting from plant-based meat to protein drinks. This article explores whether beyond meat's pivot pr...
Unisys (UIS) 2026 earnings could hinge on services growth, margin discipline, and backlog strength. This guide breaks...
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
Salesforce stock today has been in the spotlight as investors weigh new AI advancements against business execution. T...
Alphabet's Gemini delays raise questions about AI leadership and stock resilience. This guide analyzes what the lag m...
A bold investing idea sits beyond Nvidia: a mid-sized AI semiconductor stock poised to outrun the market over the nex...
Northeast metros are clearing supply faster than many Sun Belt peers, boosting seller leverage as spring demand retur...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Biotech stocks can swing wildly on quarterly results and guidance. This article unpacks why genedx stock plummeting t...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...